Fig. 1From: Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugsCytotoxicity assay and IC50 of ten common pancreatic ductal adenocarcinoma (PDAC) cell lines, AsPC-1 (A), BxPC-3 (B), CFPAC (C), CAPAN-1 (D), HPAFII (E), MIA PaCa-2 (F), PANC-1 (G), Patu-8988 (H), SW1990 (I) and T3M4 (J), to five first-line chemotherapeutic drugs. The most resistant and sensitive drugs of each cell line were shown in the red and blue box respectivelyBack to article page